SERB Pharmaceuticals is a dynamic and growing pharmaceutical company that is dedicated to providing support and treatment options for patients with critical conditions. With over 30 years of experience, we have made it our mission to offer hope to patients and their families by developing products that treat complex and life-threatening conditions. Our portfolio of products is focused on emergency care and rare diseases.

In the field of emergency care, we have the broadest antidote portfolio in the world, offering medical countermeasures for chemical, biological, radiological, and nuclear risks. This makes us a trusted partner for hospitals, emergency services, and governments. In the area of rare diseases, we are committed to helping patients with rare neurologic syndromes, metabolic disorders, and rare conditions in oncology.

We work tirelessly to provide these patients with the diagnosis and treatment options they deserve. At SERB Pharmaceuticals, we are not only dedicated to developing innovative products, but we also strive to optimize every stage of the pharmaceutical value chain. With a global commercial platform, a pipeline of R&D projects, and a team of industry experts, we ensure that our medicines are manufactured to the highest standards and reliably supplied worldwide.

We are proud to be an essential partner to healthcare professionals and are committed to delivering critical, life-saving medicines for patients